Cevimeline

Drug Details

Cevimeline, marketed under the brand name Evoxac, is prescribed to alleviate symptoms of dry mouth caused by Sjögren's syndrome, an immune disorder. As a cholinergic agonist, Cevimeline functions by activating specific receptors in the salivary glands, thereby increasing saliva production. This action helps alleviate the discomfort associated with dry mouth, making it easier to speak and swallow. Typically, it is administered in a 30 mg capsule form, taken orally three times daily. Common side effects may include excessive sweating, nausea, and headache. Always consult healthcare professionals for personalized medical advice before starting any new medication.